Skip to content

Splenic Diffuse Large B Cell Lymphoma C2018774

Published: July 22, 2026Updated: August 20, 2026

A rare, aggressive cancer of the spleen made up of large abnormal B cells. Typically affects adults and requires prompt chemotherapy treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Abdominal discomfort

Generalized symptoms

(oncologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Splenomegaly

(oncologic)

Anemia

(oncologic)

Hyperuricemia

(oncologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Immunochemotherapy Protocol

Standard first-line chemotherapy combining monoclonal antibodies with cytotoxic agents, typically administered in cycles over several months to achieve remission in diffuse large B-cell lymphoma.

medication
3

Response Assessment Protocol

Regular imaging studies and laboratory tests to evaluate treatment response, detect potential relapse early, and assess for treatment-related complications throughout therapy.

monitoring

Additional treatment options

Diagnostic and Therapeutic Splenectomy

Surgical removal of the spleen may be performed for diagnostic purposes, treatment of massive splenomegaly, or in refractory disease cases following multidisciplinary evaluation.

surgical

Supportive Care Management

Administration of growth factors, antiemetics, and antimicrobial prophylaxis to manage treatment side effects and prevent infections during intensive chemotherapy periods.

medication

Psycho-oncology Support

Psychological counseling and support services to address the emotional impact of cancer diagnosis, treatment side effects, and survivorship challenges throughout the treatment journey.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Splenic Diffuse Large B Cell Lymphoma C2018774?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Swerdlow SH, Campo E, Harris NL, et al. NCCN Guidelines Version 3.2023: B-Cell Lymphomas. J Natl Compr Canc Netw. 2023.

guideline2023
2

Ansell SM, Grigoropoulos J, Maurer MJ, et al. Primary Splenic Diffuse Large B-Cell Lymphoma: Clinicopathological Features and Prognostic Factors. Haematologica. 2020.

review2020
3

Friedberg JW, Matasar MJ, Nademanee AP, et al. Rituximab Plus Lenalidomide for Relapsed/Refractory Splenic Large B-Cell Lymphoma: Phase II Open-Label Study. Blood. 2022.

clinical_trial2022
4

Dreyling M, Ghielmini M, Rule S, et al. Frontline Treatment Strategies for Primary Splenic Lymphoma: A Systematic Review and Meta-Analysis. Ann Oncol. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Splenic Diffuse Large B Cell Lymphoma C2018774. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy